The structural biochemistry of the superoxide dismutases

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1804, Issue 2, 2010, Pages 245-262

  Perry, J J P ^a,b   Shin, D S ^a   Getzoff, E D ^a   Tainer, J A ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b AMRITA UNIVERSITY   (India)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Lou Gehrig's disease; Protein crystallography; Reactive oxygen species; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DIMER; DISULFIDE; HYDROGEN; IRON SUPEROXIDE DISMUTASE; LIGAND; MANGANESE SUPEROXIDE DISMUTASE; METAL; NICKEL SUPEROXIDE DISMUTASE; PHOSPHATE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BIOCHEMISTRY; BIOLOGY; CATALYSIS; CLINICAL RESEARCH; COMPREHENSION; CRYSTAL STRUCTURE; DIFFUSION; DISULFIDE BOND; ELECTRICITY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME STRUCTURE; FIBER; HUMAN; HYDROGEN BOND; METAL BINDING; MUTATION; MUTATIONAL ANALYSIS; NEGATIVE FEEDBACK; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN MOTIF; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SUPEROXIDE DISMUTASE;

EID: 74649085703     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.11.004     Document Type: Review

References (289)

1. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969) 6049-6055
2. Fridovich I. Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J. Biol. Chem. 272 (1997) 18515-18517
3. N. Lane, Oxygen: The Molecule that Made the World Oxford University Press, USA 2003.
4. Fridovich I. Superoxide dismutases. Adv. Enzymol. Relat. Areas Mol. Biol. 58 (1986) 61-97
5. Babior B.M., Kipnes R.S., and Curnutte J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 52 (1973) 741-744
6. Johnston Jr. R.B., Godzik C.A., and Cohn Z.A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J. Exp. Med. 148 (1978) 115-127
7. Sawyer D.T.V., and Valentine J.S. How super is superoxide. Acc. Chem. Res. 14 (1981) 393-400
8. Sawyer D.T.V., and Valentine J.S. How innocuous is superoxide? Reply to comments. Acc. Chem. Res. 15 (1982) 200
9. McCord J.M., Keele Jr. B.B., and Fridovich I. An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 68 (1971) 1024-1027
10. Halliwell B., and J.M.C. Superoxide and superoxide-dependent formation of hyrdoxyl radicals are important in oxygen-toxicity. Trends Biochem. Sci. 7 (1982) 270-272
11. Carlioz A., and Touati D. Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life?. EMBO J. 5 (1986) 623-630
12. McCord J.M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science 185 (1974) 529-531
13. Salin M.L., and McCord J.M. Free radicals and inflammation. Protection of phagocytosine leukocytes by superoxide dismutase. J. Clin. Invest. 56 (1975) 1319-1323
14. Petrone W.F., English D.K., Wong K., and McCord J.M. Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 1159-1163
15. Turner S.R., Tainer J.A., and Lynn W.S. Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets. Nature 257 (1975) 680-681
16. Imlay J.A., Chin S.M., and Linn S. Toxic DNA damage by hydrogen peroxide through the Fenton reaction in vivo and in vitro. Science 240 (1988) 640-642
17. Imlay J.A., and Linn S. DNA damage and oxygen radical toxicity. Science 240 (1988) 1302-1309
18. Perry J.J., Fan L., and Tainer J.A. Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair. Neuroscience 145 (2007) 1280-1299
19. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59 (1992) 1609-1623
20. Darley-Usmar V., and Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm. Res. 13 (1996) 649-662
21. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313 Pt. 1 (1996) 17-29
22. Stadtman E.R., and Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10 (1997) 485-494
23. Halliwell B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br. J. Exp. Pathol. 70 (1989) 737-757
24. Oberley L.W., and Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Res. 39 (1979) 1141-1149
25. Granger D.N., Rutili G., and McCord J.M. Superoxide radicals in feline intestinal ischemia. Gastroenterology 81 (1981) 22-29
26. Parks D.A., Bulkley G.B., Granger D.N., Hamilton S.R., and McCord J.M. Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology 82 (1982) 9-15
27. Tolmasoff J.M., Ono T., and Cutler R.G. Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species. Proc. Natl. Acad. Sci. U. S. A. 77 (1980) 2777-2781
28. Orr W.C., and Sohal R.S. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263 (1994) 1128-1130
29. Naslund U., Haggmark S., Johansson G., Marklund S.L., Reiz S., and Oberg A. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion model. J. Mol. Cell Cardiol. 18 (1986) 1077-1084
30. Costa C.A., Amaral T.A., Carvalho L.C., Ognibene D.T., da Silva A.F., Moss M.B., Valenca S.S., de Moura R.S., and Resende A.C. Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. Am. J. Hypertens. 22 12 (2009) 1242-1249 [Electronic publication ahead of print 2009 Sep 24]
31. Rahman I. Antioxidant therapeutic advances in COPD. Ther. Adv. Respir. Dis. 2 (2008) 351-374
32. Kawakami S., Matsuda A., Sunagawa T., Noda Y., Kaneko T., Tahara S., Hiraumi Y., Adachi S., Matsui H., Ando K., Fujita T., Maruyama N., Shirasawa T., and Shimizu T. Antioxidant, EUK-8, prevents murine dilated cardiomyopathy. Circ. J. 73 (2009) 2125-2134
33. Kim B.S., Cha H.N., Kim Y.W., Kim J.Y., Dan J.M., and Park S.Y. Inhibition of lipid infusion-induced skeletal muscle insulin resistance by cotreatment with tempol and glutathione in mice. J. Pharmacol. Sci. 110 (2009) 370-380
34. Shopova V.L., Dancheva V.Y., Salovsky P.T., and Stoyanova A.M. Protective effects of a superoxide dismutase/catalase mimetic compound against paraquat pneumotoxicity in rat lung. Respirology 14 (2009) 504-510
35. Kawakami T., Urakami S., Hirata H., Tanaka Y., Nakajima K., Enokida H., Shiina H., Ogishima T., Tokizane T., Kawamoto K., Miura K., Ishii N., and Dahiya R. Superoxide dismutase analog (Tempol: 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine 1-oxyl) treatment restores erectile function in diabetes-induced impotence. Int. J. Impot. Res. 21 (2009) 348-355 [Electronic publication ahead of print 25 June 2009]
36. Peixoto E.B., Pessoa B.S., Biswas S.K., and Lopes de Faria J.B. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am. J. Nephrol. 29 (2009) 309-318
37. Abdallah D.M., El-Abhar H.S., and Abdel-Aziz D.H. TEMPOL, a membrane-permeable radical scavenger, attenuates gastric mucosal damage induced by ischemia/reperfusion: a key role for superoxide anion. Eur. J. Pharmacol. 603 (2009) 93-97
38. Church S.L., Grant J.W., Ridnour L.A., Oberley L.W., Swanson P.E., Meltzer P.S., and Trent J.M. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 3113-3117
39. Paschen W.U. W, Problems concerning the biochemical action of superoxide dismutase (erthrocuperin). Hoppe Seylers Z. Physiol. Chem. 356 (1975) 727-737
40. Beyer Jr. W.F., Wang Y., and Fridovich I. Phosphate inhibition of the copper-and zinc-containing superoxide dismutase: a reexamination. Biochemistry 25 (1986) 6084-6088
41. Tainer J.A., Getzoff E.D., Richardson J.S., and Richardson D.C. Structure and mechanism of copper, zinc superoxide dismutase. Nature 306 (1983) 284-287
42. Getzoff E.D., Tainer J.A., Weiner P.K., Kollman P.A., Richardson J.S., and Richardson D.C. Electrostatic recognition between superoxide and copper, zinc superoxide dismutase. Nature 306 (1983) 287-290
43. Mota de Freitas D., and Valentine J.S. Phosphate is an inhibitor of copper-zinc superoxide dismutase. Biochemistry 23 (1984) 2079-2082
44. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Hallewell R.A., Pericack-Vance M.A., and Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 261 (1993) 1047-1051
45. Antonyuk S., Elam J.S., Hough M.A., Strange R.W., Doucette P.A., Rodriguez J.A., Hayward L.J., Valentine J.S., Hart P.J., and Hasnain S.S. Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg. Protein. Sci. 14 (2005) 1201-1213
46. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
47. Cao X., Antonyuk S.V., Seetharaman S.V., Whitson L.J., Taylor A.B., Holloway S.P., Strange R.W., Doucette P.A., Valentine J.S., Tiwari A., Hayward L.J., Padua S., Cohlberg J.A., Hasnain S.S., and Hart P.J. Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis. J. Biol. Chem. 283 (2008) 16169-16177
48. DiDonato M., Craig L., Huff M.E., Thayer M.M., Cardoso R.M., Kassmann C.J., Lo T.P., Bruns C.K., Powers E.T., Kelly J.W., Getzoff E.D., and Tainer J.A. ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization. J. Mol. Biol. 332 (2003) 601-615
49. Ding F., and Dokholyan N.V. Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 19696-19701
50. Elam J.S., Taylor A.B., Strange R., Antonyuk S., Doucette P.A., Rodriguez J.A., Hasnain S.S., Hayward L.J., Valentine J.S., Yeates T.O., and Hart P.J. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Biol. 10 (2003) 461-467
51. Gidalevitz T., Krupinski T., Garcia S., and Morimoto R.I. Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet. 5 (2009) e1000399
52. Hornberg A., Logan D.T., Marklund S.L., and Oliveberg M. The coupling between disulphide status, metallation and dimer interface strength in Cu/Zn superoxide dismutase. J. Mol. Biol. 365 (2007) 333-342
53. Hough M.A., Grossmann J.G., Antonyuk S.V., Strange R.W., Doucette P.A., Rodriguez J.A., Whitson L.J., Hart P.J., Hayward L.J., Valentine J.S., and Hasnain S.S. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5976-5981
54. Lindberg M.J., Bystrom R., Boknas N., Andersen P.M., and Oliveberg M. Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutants. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9754-9759
55. Nordlund A., and Oliveberg M. SOD1-associated ALS: a promising system for elucidating the origin of protein-misfolding disease. HFSP J. 2 (2008) 354-364
56. Roberts B.R., Tainer J.A., Getzoff E.D., Malencik D.A., Anderson S.R., Bomben V.C., Meyers K.R., Karplus P.A., and Beckman J.S. Structural characterization of zinc-deficient human superoxide dismutase and implications for ALS. J. Mol. Biol. 373 (2007) 877-890
57. Rumfeldt J.A., Lepock J.R., and Meiering E.M. Unfolding and folding kinetics of amyotrophic lateral sclerosis-associated mutant Cu,Zn superoxide dismutases. J. Mol. Biol. 385 (2009) 278-298
58. Shaw B.F., Durazo A., Nersissian A.M., Whitelegge J.P., Faull K.F., and Valentine J.S. Local unfolding in a destabilized, pathogenic variant of superoxide dismutase 1 observed with H/D exchange and mass spectrometry. J. Biol. Chem. 281 (2006) 18167-18176
59. Shin D.S., Didonato M., Barondeau D.P., Hura G.L., Hitomi C., Berglund J.A., Getzoff E.D., Cary S.C., and Tainer J.A. Superoxide dismutase from the eukaryotic thermophile Alvinella pompejana: structures, stability, mechanism, and insights into amyotrophic lateral sclerosis. J. Mol. Biol. 385 (2009) 1534-1555
60. Strange R.W., Yong C.W., Smith W., and Hasnain S.S. Molecular dynamics using atomic-resolution structure reveal structural fluctuations that may lead to polymerization of human Cu-Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10040-10044
61. Tiwari A., Liba A., Sohn S.H., Seetharaman S.V., Bilsel O., Matthews C.R., Hart P.J., Valentine J.S., and Hayward L.J. Metal deficiency increases aberrant hydrophobicity of mutant superoxide dismutases that cause amyotrophic lateral sclerosis. J. Biol. Chem. 284 40 (2009) 27746-27758 [Electronic publication ahead of print 2009 Aug 3]
62. Wang J., Farr G.W., Hall D.H., Li F., Furtak K., Dreier L., and Horwich A.L. An ALS-linked mutant SOD1 produces a locomotor defect associated with aggregation and synaptic dysfunction when expressed in neurons of Caenorhabditis elegans. PLoS Genet. 5 (2009) e1000350
63. Wang Q., Johnson J.L., Agar N.Y., and Agar J.N. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol. 6 (2008) e170
64. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van den Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Robert Horvitz H., and Brown Jr. R.H. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
65. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., and Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271 (1996) 515-518
66. Majoor-Krakauer D., Willems P.J., and Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin. Genet. 63 (2003) 83-101
67. Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr. Neurol. Neurosci. Rep. 6 (2006) 37-46
68. Smith M.W., and Doolittle R.F. A comparison of evolutionary rates of the two major kinds of superoxide dismutase. J. Mol. Evol. 34 (1992) 175-184
69. Mann T., and Keilin D. Haemocuprein and hepatocuprein, copper-protein compounds of blood and liver in mammals. Proc. Roy. Soc. Ser. B-Biol. Sci. 126 (1938) 303-315
70. Kimmel J.R., Markowitz H., and Brown D.M. Some chemical and physical properties of erythrocuprein. J. Biol. Chem. 234 (1959) 46-50
71. Markowitz H., Cartwright G.E., and Wintrobe M.M. Studies on copper metabolism. XXVII. The isolation and properties of an erythrocyte cuproprotein (erythrocuprein). J. Biol. Chem. 234 (1959) 40-45
72. Porter H., Folch J., and Cerebrocuprein I. A copper-containing protein isolated from brain. J. Neurochem. 1 (1957) 260-271
73. Tainer J.A., Getzoff E.D., Beem K.M., Richardson J.S., and Richardson D.C. Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase. J. Mol. Biol. 160 (1982) 181-217
74. Getzoff E.D., Cabelli D.E., Fisher C.L., Parge H.E., Viezzoli M.S., Banci L., and Hallewell R.A. Faster superoxide dismutase mutants designed by enhancing electrostatic guidance. Nature 358 (1992) 347-351
75. Parge H.E., Hallewell R.A., and Tainer J.A. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6109-6113
76. Djinovic K., Gatti G., Coda A., Antolini L., Pelosi G., Desideri A., Falconi M., Marmocchi F., Rolilio G., and Bolognesi M. Structure solution and molecular dynamics refinement of the yeast Cu,Zn enzyme superoxide dismutase. Acta Crystallogr. B. 47 Pt 6 (1991) 918-927
77. Djinovic K., Gatti G., Coda A., Antolini L., Pelosi G., Desideri A., Falconi M., Marmocchi F., Rotilio G., and Bolognesi M. Crystal structure of yeast Cu,Zn superoxide dismutase. Crystallographic refinement at 2.5 A resolution. J. Mol. Biol. 225 (1992) 791-809
78. Ogihara N.L., Parge H.E., Hart P.J., Weiss M.S., Goto J.J., Crane B.R., Tsang J., Slater K., Roe J.A., Valentine J.S., Eisenberg D., and Tainer J.A. Unusual trigonal-planar copper configuration revealed in the atomic structure of yeast copper-zinc superoxide dismutase. Biochemistry 35 (1996) 2316-2321
79. Cardoso R.M., Silva C.H., Ulian de Araujo A.P., Tanaka T., Tanaka M., and Garratt R.C. Structure of the cytosolic Cu,Zn superoxide dismutase from Schistosoma mansoni. Acta Crystallogr. D. Biol. Crystallogr. 60 (2004) 1569-1578
80. Carugo K.D., Battistoni A., Carri M.T., Polticelli F., Desideri A., Rotilio G., Coda A., Wilson K.S., and Bolognesi M. Three-dimensional structure of Xenopus laevis Cu,Zn superoxide dismutase b determined by X-ray crystallography at 1.5 A resolution. Acta Crystallogr. D. Biol. Crystallogr. 52 (1996) 176-188
81. Kitagawa Y., Tanaka N., Hata Y., Kusunoki M., Lee G.P., Katsube Y., Asada K., Aibara S., and Morita Y. Three-dimensional structure of Cu,Zn-superoxide dismutase from spinach at 2.0 A resolution. J. Biochem. (Tokyo) 109 (1991) 477-485
82. Yogavel M., Mishra P.C., Gill J., Bhardwaj P.K., Dutt S., Kumar S., Ahuja P.S., and Sharma A. Structure of a superoxide dismutase and implications for copper-ion chelation. Acta Crystallogr. D. Biol. Crystallogr. D64 (2008) 892-901
83. Banci L., Bertini I., Cramaro F., Del Conte R., and Viezzoli M.S. The solution structure of reduced dimeric copper zinc superoxide dismutase. The structural effects of dimerization. Eur. J. Biochem. 269 (2002) 1905-1915
84. Richardson J.S. β-Sheet topology and the relatedness of proteins. Nature 268 (1977) 495-500
85. Getzoff E.D., Tainer J.A., Stempien M.M., Bell G.I., and Hallewell R.A. Evolution of CuZn superoxide dismutase and the Greek key beta-barrel structural motif. Proteins 5 (1989) 322-336
86. Hallewell R.A., Imlay K.C., Lee P., Fong N.M., Gallegos C., Getzoff E.D., Tainer J.A., Cabelli D.E., Tekamp-Olson P., Mullenbach G.T., and Cousens L.S. Thermostabilization of recombinant human and bovine CuZn superoxide dismutases by replacement of free cysteines. Biochem. Biophys. Res. Commun. 181 (1991) 474-480
87. Roberts V.A., Freeman H.C., Olson A.J., Tainer J.A., and Getzoff E.D. Electrostatic orientation of the electron-transfer complex between plastocyanin and cytochrome c. J. Biol. Chem. 266 (1991) 13431-13441
88. Hough M.A., and Hasnain S.S. Structure of fully reduced bovine copper zinc superoxide dismutase at 1.15 A. Structure 11 (2003) 937-946
89. Strange R.W., Antonyuk S.V., Hough M.A., Doucette P.A., Valentine J.S., and Hasnain S.S. Variable metallation of human superoxide dismutase: atomic resolution crystal structures of Cu-Zn, Zn-Zn and As-isolated wild-type enzymes. J. Mol. Biol. 356 (2006) 1152-1162
90. Bordo D., Djinovic K., and Bolognesi M. Conserved patterns in the Cu,Zn superoxide dismutase family. J. Mol. Biol. 238 (1994) 366-386
91. Boissinot M., Karnas S., Lepock J.R., Cabelli D.E., Tainer J.A., Getzoff E.D., and Hallewell R.A. Function of the Greek key connection analysed using circular permutants of superoxide dismutase. EMBO J. 16 (1997) 2171-2178
92. Crane B.R., Arvai A.S., Gachhui R., Wu C., Ghosh D.K., Getzoff E.D., Stuehr D.J., and Tainer J.A. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 278 (1997) 425-431
93. Crane B.R., Arvai A.S., Ghosh D.K., Wu C., Getzoff E.D., Stuehr D.J., and Tainer J.A. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279 (1998) 2121-2126
94. Fisher C.L., Cabelli D.E., Hallewell R.A., Beroza P., Lo T.P., Getzoff E.D., and Tainer J.A. Computational, pulse-radiolytic, and structural investigations of lysine-136 and its role in the electrostatic triad of human Cu,Zn superoxide dismutase. Proteins 29 (1997) 103-112
95. Fisher C.L., Cabelli D.E., Tainer J.A., Hallewell R.A., and Getzoff E.D. The role of arginine 143 in the electrostatics and mechanism of Cu,Zn superoxide dismutase: computational and experimental evaluation by mutational analysis. Proteins 19 (1994) 24-34
96. Fisher C.L., Hallewell R.A., Roberts V.A., Tainer J.A., and Getzoff E.D. Probing the structural basis for enzyme-substrate recognition in Cu,Zn superoxide dismutase. Free Radic. Res. Commun. 12-13 Pt. 1 (1991) 287-296
97. Roberts V.A., Fisher C.L., Redford S.M., McRee D.E., Parge H.E., Getzoff E.D., and Tainer J.A. Mechanism and atomic structure of superoxide dismutase. Free Radic. Res. Commun. 12-13 Pt 1 (1991) 269-278
98. Tainer J.A., Hallewell R.A., Roberts V.A., Parge H.E., and Getzoff E.D. Probing enzyme-substrate recognition and catalytic mechanism in Cu,Zn superoxide dismutase. Basic Life Sci. 49 (1988) 635-640
99. Hart P.J., Balbirnie M.M., Ogihara N.L., Nersissian A.M., Weiss M.S., Valentine J.S., and Eisenberg D. A structure-based mechanism for copper-zinc superoxide dismutase. Biochemistry 38 (1999) 2167-2178
100. Ferraroni M., Rypniewski W.R., Bruni B., Orioli P., and Mangani S. Crystallographic determination of reduced bovine superoxide dismutase at pH 5.0 and of anion binding to its active site. J. Biol. Inorg. Chem. 3 (1998) 411-422
101. Smirnov V.V., and Roth J.P. Mechanisms of electron transfer in catalysis by copper zinc superoxide dismutase. J. Am. Chem. Soc. 128 (2006) 16424-16425
102. Antonyuk S.V., Strange R.W., Marklund S.L., and Hasnain S.S. The structure of human extracellular copper-zinc superoxide dismutase at 1.7 A resolution: insights into heparin and collagen binding. J. Mol. Biol. 388 (2009) 310-326
103. Marklund S.L. Extracellular superoxide dismutase in human tissues and human cell lines. J. Clin. Invest. 74 (1984) 1398-1403
104. Marklund S.L. Product of extracellular-superoxide dismutase catalysis. FEBS Lett. 184 (1985) 237-239
105. Benov L., Chang L.Y., Day B., and Fridovich I. Copper, zinc superoxide dismutase in Escherichia coli: periplasmic localization. Arch. Biochem. Biophys. 319 (1995) 508-511
106. Canvin J., Langford P.R., Wilks K.E., and Kroll J.S. Identification of sodC encoding periplasmic [Cu,Zn]-superoxide dismutase in Salmonella. FEMS. Microbiol. Lett. 136 (1996) 215-220
107. Kroll J.S., Langford P.R., and Loynds B.M. Copper-zinc superoxide dismutase of Haemophilus influenzae and H. parainfluenzae. J. Bacteriol. 173 (1991) 7449-7457
108. Kroll J.S., Langford P.R., Wilks K.E., and Keil A.D. Bacterial [Cu,Zn]-superoxide dismutase: phylogenetically distinct from the eukaryotic enzyme, and not so rare after all!. Microbiology 141 Pt. 9 (1995) 2271-2279
109. Lainson F.A., Thomson N., Rowe H.A., Langford P.R., Aitchison K.D., Donachie W., and Kroll J.S. Occurrence of [copper, zinc]-cofactored superoxide dismutase in Pasteurella haemolytica and its serotype distribution. FEMS Microbiol. Lett. 142 (1996) 11-17
110. Langford P.R., Loynds B.M., and Kroll J.S. Cloning and molecular characterization of Cu,Zn superoxide dismutase from Actinobacillus pleuropneumoniae. Infect. Immun. 64 (1996) 5035-5041
111. Stabel T.J., Sha Z., and Mayfield J.E. Periplasmic location of Brucella abortus Cu/Zn superoxide dismutase. Vet. Microbiol. 38 (1994) 307-314
112. Farrant J.L., Sansone A., Canvin J.R., Pallen M.J., Langford P.R., Wallis T.S., Dougan G., and Kroll J.S. Bacterial copper-and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis. Mol. Microbiol. 25 (1997) 785-796
113. Tatum F.M., Detilleux P.G., Sacks J.M., and Halling S.M. Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infect. Immun. 60 (1992) 2863-2869
114. Wilks K.E., Dunn K.L., Farrant J.L., Reddin K.M., Gorringe A.R., Langford P.R., and Kroll J.S. Periplasmic superoxide dismutase in meningococcal pathogenicity. Infect. Immun. 66 (1998) 213-217
115. Battistoni A. Role of prokaryotic Cu,Zn superoxide dismutase in pathogenesis. Biochem. Soc. Trans. 31 (2003) 1326-1329
116. De Groote M.A., Ochsner U.A., Shiloh M.U., Nathan C., McCord J.M., Dinauer M.C., Libby S.J., Vazquez-Torres A., Xu Y., and Fang F.C. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13997-14001
117. Bourne Y., Redford S.M., Steinman H.M., Lepock J.R., Tainer J.A., and Getzoff E.D. Novel dimeric interface and electrostatic recognition in bacterial Cu,Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 12774-12779
118. Redford S.M., McRee D.E., Getzoff E.D., Steinman H.M., and Tainer J.A. Crystallographic characterization of a Cu,Zn superoxide dismutase from Photobacterium leiognathi. J. Mol. Biol. 212 (1990) 449-451
119. Bordo D., Matak D., Djinovic-Carugo K., Rosano C., Pesce A., Bolognesi M., Stroppolo M.E., Falconi M., Battistoni A., and Desideri A. Evolutionary constraints for dimer formation in prokaryotic Cu,Zn superoxide dismutase. J. Mol. Biol. 285 (1999) 283-296
120. Forest K.T., Langford P.R., Kroll J.S., and Getzoff E.D. Cu,Zn superoxide dismutase structure from a microbial pathogen establishes a class with a conserved dimer interface. J. Mol. Biol. 296 (2000) 145-153
121. Pesce A., Battistoni A., Stroppolo M.E., Polizio F., Nardini M., Kroll J.S., Langford P.R., O'Neill P., Sette M., Desideri A., and Bolognesi M. Functional and crystallographic characterization of Salmonella typhimurium Cu,Zn superoxide dismutase coded by the sodCI virulence gene. J. Mol. Biol. 302 (2000) 465-478
122. Pesce A., Capasso C., Battistoni A., Folcarelli S., Rotilio G., Desideri A., and Bolognesi M. Unique structural features of the monomeric Cu,Zn superoxide dismutase from Escherichia coli, revealedZ by X-ray crystallography. J. Mol. Biol. 274 (1997) 408-420
123. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2 (2001) 806-819
124. Charcot J.M., and Joffory A. Deux cas d'atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere. Arch. Physiol. Neurol. Pathol. 2 (1869) 744-754
125. Siddique T., and Deng H.X. Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 5 (1996) 1465-1470
126. Dobson C.M. Protein folding and its links with human disease. Biochem. Soc. Symp. (2001) 1-26
127. Andersen P.M. Genetics of sporadic ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2 Suppl. 1 (2001) S37-S41
128. Gaudette M., Hirano M., and Siddique T. Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1 (2000) 83-89
129. Julien J.P. ALS: astrocytes move in as deadly neighbors. Nat. Neurosci. 10 (2007) 535-537
130. Potter S.Z., and Valentine J.S. The perplexing role of copper-zinc superoxide dismutase in amyotrophic lateral sclerosis (Lou Gehrig's disease). J. Biol. Inorg. Chem. 8 (2003) 373-380
131. Rodriguez J.A., Shaw B.F., Durazo A., Sohn S.H., Doucette P.A., Nersissian A.M., Faull K.F., Eggers D.K., Tiwari A., Hayward L.J., and Valentine J.S. Destabilization of apoprotein is insufficient to explain Cu,Zn-superoxide dismutase-linked ALS pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10516-10521
132. Shaw B.F., and Valentine J.S. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?. Trends Biochem. Sci. 32 (2007) 78-85
133. Wong P.C., and Borchelt D.R. Motor neuron disease caused by mutations in superoxide dismutase 1. Curr. Opin. Neurol. 8 (1995) 294-301
134. Brown Jr. R.H. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80 (1995) 687-692
135. Crow J.P., Ye Y.Z., Strong M., Kirk M., Barnes S., and Beckman J.S. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J. Neurochem. 69 (1997) 1945-1953
136. Beckman J.S., Carson M., Smith C.D., and Koppenol W.H. ALS, SOD and peroxynitrite. Nature 364 (1993) 584
137. Zhang H., Joseph J., Gurney M., Becker D., and Kalyanaraman B. Bicarbonate enhances peroxidase activity of Cu,Zn-superoxide dismutase. Role of carbonate anion radical and scavenging of carbonate anion radical by metalloporphyrin antioxidant enzyme mimetics. J. Biol. Chem. 277 (2002) 1013-1020
138. Cleveland D.W., and Liu J. Oxidation versus aggregation - how do SOD1 mutants cause ALS?. Nat. Med. 6 (2000) 1320-1321
139. Hirano A., Donnenfeld H., Sasaki S., and Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 43 (1984) 461-470
140. Wanker E.E. Protein aggregation in Huntington's and Parkinson's disease: implications for therapy. Mol. Med. Today 6 (2000) 387-391
141. Soto C. Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 498 (2001) 204-207
142. Durham H.D., Roy J., Dong L., and Figlewicz D.A. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. J. Neuropathol. Exp. Neurol. 56 (1997) 523-530
143. Johnston J.A., Dalton M.J., Gurney M.E., and Kopito R.R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 12571-12576
144. Shibata N., Hirano A., Kobayashi M., Siddique T., Deng H.X., Hung W.Y., Kato T., and Asayama K. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 55 (1996) 481-490
145. Kato S., Sumi-Akamaru H., Fujimura H., Sakoda S., Kato M., Hirano A., Takikawa M., and Ohama E. Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation. Acta. Neuropathol. (Berl.) 102 (2001) 233-238
146. Chou S.M., Wang H.S., and Komai K. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J. Chem. Neuroanat. 10 (1996) 249-258
147. Nicholls D.G., and Budd S.L. Mitochondria and neuronal survival. Physiol. Rev. 80 (2000) 315-360
148. Jaarsma D., Rognoni F., van Duijn W., Verspaget H.W., Haasdijk E.D., and Holstege J.C. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta. Neuropathol. (Berl.) 102 (2001) 293-305
149. Kong J., and Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18 (1998) 3241-3250
150. Ferri K.F., and Kroemer G. Mitochondria-the suicide organelles. BioEssays 23 (2001) 111-115
151. Pasinelli P., Borchelt D.R., Houseweart M.K., Cleveland D.W., and Brown Jr. R.H. Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase [published erratum appears in Proc Natl Acad Sci U S A 1999 Mar 16;96(6):3330]. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15763-15768
152. Rabizadeh S., Gralla E.B., Borchelt D.R., Gwinn R., Valentine J.S., Sisodia S., Wong P., Lee M., Hahn H., and Bredesen D.E. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3024-3028
153. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., and Friedlander R.M. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288 (2000) 335-339
154. Pasinelli P., Houseweart M.K., Brown Jr. R.H., and Cleveland D.W. Caspase-1 and-3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13901-13906
155. Polymenidou M., and Cleveland D.W. Motor neuron disease: The curious ways of ALS. Nature 454 (2008) 284-285
156. Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., Noguchi T., Matsuzawa A., Takeda K., and Ichijo H. ALS-linked mutant SOD1 induces ER stress-and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22 (2008) 1451-1464
157. Harraz M.M., Marden J.J., Zhou W., Zhang Y., Williams A., Sharov V.S., Nelson K., Luo M., Paulson H., Schoneich C., and Engelhardt J.F. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J. Clin. Invest. 118 (2008) 659-670
158. Lilley B.N., and Ploegh H.L. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429 (2004) 834-840
159. Babior B.M., and oxidase N. Curr. Opin. Immunol. 16 (2004) 42-47
160. Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R., and Julien J.P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 9 (2006) 108-118
161. Wang J., Farr G.W., Zeiss C.J., Rodriguez-Gil D.J., Wilson J.H., Furtak K., Rutkowski D.T., Kaufman R.J., Ruse C.I., Yates III J.R., Perrin S., Feany M.B., and Horwich A.L. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 1392-1397
162. Kieran D., Hafezparast M., Bohnert S., Dick J.R., Martin J., Schiavo G., Fisher E.M., and Greensmith L. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 169 (2005) 561-567
163. Zhang F., Strom A.L., Fukada K., Lee S., Hayward L.J., and Zhu H. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J. Biol. Chem. 282 (2007) 16691-16699
164. Tubbs J.L., Latypov V., Kanugula S., Butt A., Melikishvili M., Kraehenbuehl R., Fleck O., Marriott A., Watson A.J., Verbeek B., McGown G., Thorncroft M., Santibanez-Koref M.F., Millington C., Arvai A.S., Kroeger M.D., Peterson L.A., Williams D.M., Fried M.G., Margison G.P., Pegg A.E., and Tainer J.A. Flipping of alkylated DNA damage bridges base and nucleotide excision repair. Nature 459 (2009) 808-813
165. Getzoff E.D., Tainer J.A., and Olson A.J. Recognition and interactions controlling the assemblies of beta barrel domains. Biophys. J. 49 (1986) 191-206
166. Hura G.L., Menon A.L., Hammel M., Rambo R.P., Poole II F.L., Tsutakawa S.E., Jenney Jr. F.E., Classen S., Frankel K.A., Hopkins R.C., Yang S.J., Scott J.W., Dillard B.D., Adams M.W., and Tainer J.A. Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS). Nat. Methods. 6 (2009) 606-612
167. Putnam C.D., Hammel M., Hura G.L., and Tainer J.A. X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. Q. Rev. Biophys. 40 (2007) 191-285
168. Teilum K., Smith M.H., Schulz E., Christensen L.C., Solomentsev G., Oliveberg M., and Akke M. Transient structural distortion of metal-free Cu/Zn superoxide dismutase triggers aberrant oligomerization. Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 18273-18278
169. Garcin E.D., Arvai A.S., Rosenfeld R.J., Kroeger M.D., Crane B.R., Andersson G., Andrews G., Hamley P.J., Mallinder P.R., Nicholls D.J., St-Gallay S.A., Tinker A.C., Gensmantel N.P., Mete A., Cheshire D.R., Connolly S., Stuehr D.J., Aberg A., Wallace A.V., Tainer J.A., and Getzoff E.D. Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase. Nat. Chem. Biol. 4 (2008) 700-707
170. Lepock J.R., Arnold L.D., Torrie B.H., Andrews B., and Kruuv J. Structural analyses of various Cu2+, Zn2+-superoxide dismutases by differential scanning calorimetry and Raman spectroscopy. Arch. Biochem. Biophys. 241 (1985) 243-251
171. Roe J.A., Butler A., Scholler D.M., Valentine J.S., Marky L., and Breslauer K.J. Differential scanning calorimetry of Cu,Zn-superoxide dismutase, the apoprotein, and its zinc-substituted derivatives. Biochemistry 27 (1988) 950-958
172. Malinowski D.P., and Fridovich I. Subunit association and side-chain reactivities of bovine erythrocyte superoxide dismutase in denaturing solvents. Biochemistry 18 (1979) 5055-5060
173. Forman H.J., and Fridovich I. On the stability of bovine superoxide dismutase. The effects of metals. J. Biol. Chem. 248 (1973) 2645-2649
174. Richardson J.S., Richardson D.C., Thomas K.A., Silverton E.W., and Davies D.R. Similarity of three-dimensional structure between the immunoglobulin domain and the copper, zinc superoxide dismutase subunit. J. Mol. Biol. 102 (1976) 221-235
175. Bhattacharyya R., and Chakrabarti P. Stereospecific interactions of proline residues in protein structures and complexes. J. Mol. Biol. 331 (2003) 925-940
176. McRee D.E., Redford S.M., Getzoff E.D., Lepock J.R., Hallewell R.A., and Tainer J.A. Changes in crystallographic structure and thermostability of a Cu,Zn superoxide dismutase mutant resulting from the removal of a buried cysteine. J. Biol. Chem. 265 (1990) 14234-14241
177. Cardoso R.M., Thayer M.M., DiDonato M., Lo T.P., Bruns C.K., Getzoff E.D., and Tainer J.A. Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase. J. Mol. Biol. 324 (2002) 247-256
178. Khare S.D., and Dokholyan N.V. Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3147-3152
179. Lepock J.R., Frey H.E., and Hallewell R.A. Contribution of conformational stability and reversibility of unfolding to the increased thermostability of human and bovine superoxide dismutase mutated at free cysteines. J. Biol. Chem. 265 (1990) 21612-21618
180. Chattopadhyay M., Durazo A., Sohn S.H., Strong C.D., Gralla E.B., Whitelegge J.P., and Valentine J.S. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 18663-18668
181. Furukawa Y., Kaneko K., Yamanaka K., O'Halloran T.V., and Nukina N. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 283 (2008) 24167-24176
182. Hart P.J., Liu H., Pellegrini M., Nersissian A.M., Gralla E.B., Valentine J.S., and Eisenberg D. Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis. Protein. Sci. 7 (1998) 545-555
183. Jonsson P.A., Graffmo K.S., Andersen P.M., Brannstrom T., Lindberg M., Oliveberg M., and Marklund S.L. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 129 (2006) 451-464
184. Zetterstrom P., Stewart H.G., Bergemalm D., Jonsson P.A., Graffmo K.S., Andersen P.M., Brannstrom T., Oliveberg M., and Marklund S.L. Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14157-14162
185. Pellequer J.L., Chen S., Roberts V.A., Tainer J.A., and Getzoff E.D. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding. J. Mol. Recognit. 12 (1999) 267-275
186. Juneja T., Pericak-Vance M.A., Laing N.G., Dave S., and Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with Glu100Gly and Ala4Val mutations in Cu,Zn superoxide dismutase. Neurology 48 (1997) 55-57
187. Lynch M., and Kuramitsu H. Expression and role of superoxide dismutases (SOD) in pathogenic bacteria. Microbes Infect. 2 (2000) 1245-1255
188. Richter C., Park J., and Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 6465-6467
189. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., and Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11 (1995) 376-381
190. Melov S., Coskun P., Patel M., Tuinstra R., Cottrell B., Jun A.S., Zastawny T.H., Dizdaroglu M., Goodman S.I., Huang T.T., Miziorko H., Epstein C.J., and Wallace D.C. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 846-851
191. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., and Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 18 (1998) 159-163
192. Melov S., Doctrow S.R., Schneider J.A., Haberson J., Patel M., Coskun P.E., Huffman K., Wallace D.C., and Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J. Neurosci. 21 (2001) 8348-8353
193. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., Coskun P.E., Ladiges W., Wolf N., Van Remmen H., Wallace D.C., and Rabinovitch P.S. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308 (2005) 1909-1911
194. Parker M.W., and Blake C.C. Crystal structure of manganese superoxide dismutase from Bacillus stearothermophilus at 2.4 A resolution. J. Mol. Biol. 199 (1988) 649-661
195. Carlioz A., Ludwig M.L., Stallings W.C., Fee J.A., Steinman H.M., and Touati D. Iron superoxide dismutase. Nucleotide sequence of the gene from Escherichia coli K12 and correlations with crystal structures. J. Biol. Chem. 263 (1988) 1555-1562
196. Ludwig M.L., Metzger A.L., Pattridge K.A., and Stallings W.C. Manganese superoxide dismutase from Thermus thermophilus. A structural model refined at 1.8 A resolution. J. Mol. Biol. 219 (1991) 335-358
197. Stoddard B.L., Howell P.L., Ringe D., and Petsko G.A. The 2.1-A resolution structure of iron superoxide dismutase from Pseudomonas ovalis. Biochemistry 29 (1990) 8885-8893
198. Borgstahl G.E., Parge H.E., Hickey M.J., Beyer Jr. W.F., Hallewell R.A., and Tainer J.A. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell 71 (1992) 107-118
199. Lah M.S., Dixon M.M., Pattridge K.A., Stallings W.C., Fee J.A., and Ludwig M.L. Structure-function in Escherichia coli iron superoxide dismutase: comparisons with the manganese enzyme from Thermus thermophilus. Biochemistry 34 (1995) 1646-1660
200. Wagner U.G., Pattridge K.A., Ludwig M.L., Stallings W.C., Werber M.M., Oefner C., Frolow F., and Sussman J.L. Comparison of the crystal structures of genetically engineered human manganese superoxide dismutase and manganese superoxide dismutase from Thermus thermophilus: differences in dimer-dimer interaction. Protein Sci. 2 (1993) 814-825
201. Borgstahl G.E., Parge H.E., Hickey M.J., Johnson M.J., Boissinot M., Hallewell R.A., Lepock J.R., Cabelli D.E., and Tainer J.A. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry 35 (1996) 4287-4297
202. Nomiyama T., Tanaka Y., Piao L., Nagasaka K., Sakai K., Ogihara T., Nakajima K., Watada H., and Kawamori R. The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J. Hum. Genet. 48 (2003) 138-141
203. Mollsten A., Marklund S.L., Wessman M., Svensson M., Forsblom C., Parkkonen M., Brismar K., Groop P.H., and Dahlquist G. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy. Diabetes 56 (2007) 265-269
204. Liu L., Zheng T., Wang N., Wang F., Li M., Jiang J., Zhao R., Li L., Zhao W., Zhu Q., and Jia W. The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes. Mol. Cell. Biochem. 322 (2009) 87-91
205. Wang S., Wang F., Shi X., Dai J., Peng Y., Guo X., Wang X., Shen H., and Hu Z. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk - a meta-analysis. Eur. J. Cancer. 48 16 (2009) 2874-2881
206. Iguchi T., Sugita S., Wang C.Y., Newman N.B., Nakatani T., and Haas G.P. MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status. In Vivo 23 (2009) 7-12
207. Zejnilovic J., Akev N., Yilmaz H., and Isbir T. Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet. Cytogenet. 189 (2009) 1-4
208. Pae C.U. Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia. Psychiatry Res. 161 (2008) 336-338
209. Mikhak B., Hunter D.J., Spiegelman D., Platz E.A., Wu K., Erdman Jr. J.W., and Giovannucci E. Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 29 (2008) 2335-2340
210. Arsova-Sarafinovska Z., Matevska N., Petrovski D., Banev S., Dzikova S., Georgiev V., Sikole A., Sayal A., Aydin A., Suturkova L., and Dimovski A.J. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer. Cell. Biochem. Funct. 26 (2008) 771-777
211. Bica C.G., de Moura da Silva L.L., Toscani N.V., da Cruz I.B., Sa G., Graudenz M.S., and Zettler C.G. MnSOD gene polymorphism association with steroid-dependent cancer. Pathol. Oncol. Res. 15 (2009) 19-24
212. Sines J., Allison S., Wierzbicki A., and McCammon J.A. Brownian dynamics simulation of the superoxide-superoxide dismutase reaction: iron and manganse enzymes. J. Phys. Chem. 94 (1990) 959-961
213. Leveque V.J., Vance C.K., Nick H.S., and Silverman D.N. Redox properties of human manganese superoxide dismutase and active-site mutants. Biochemistry 40 (2001) 10586-10591
214. Tierney D.L., Fee J.A., Ludwig M.L., and Penner-Hahn J.E. X-ray absorption spectroscopy of the iron site in Escherichia coli Fe(III) superoxide dismutase. Biochemistry 34 (1995) 1661-1668
215. Whittaker M.M., and Whittaker J.W. Low-temperature thermochromism marks a change in coordination for the metal ion in manganese superoxide dismutase. Biochemistry 35 (1996) 6762-6770
216. Fee J.A., McClune G.J., O'Neill P., and Fielden E.M. Saturation behavior of superoxide dismutation catalyzed by the iron containing superoxide dismutase of E. coli B. Biochem. Biophys. Res. Commun. 100 (1981) 377-384
217. Benovic J., Tillman T., Cudd A., and Fridovich I. Electrostatic facilitation of the reaction catalyzed by the manganese-containing and the iron-containing superoxide dismutases. Arch. Biochem. Biophys. 221 (1983) 329-332
218. Miller A.F., Sorkin D.L., and Padmakumar K. Anion binding properties of reduced and oxidized iron-containing superoxide dismutase reveal no requirement for tyrosine 34. Biochemistry 44 (2005) 5969-5981
219. Bull C.N., Yoshida T., and Fee J.A. Kinetic-studies of superoxide dismutasese: properties of the manganese-containing protein from Thermus-thermophilus. J. Am. Chem. Soc. 113 (1991) 4069-4076
220. Jackson T.A., Karapetian A., Miller A.F., and Brunold T.C. Probing the geometric and electronic structures of the low-temperature azide adduct and the product-inhibited form of oxidized manganese superoxide dismutase. Biochemistry 44 (2005) 1504-1520
221. Silverman D.N., and Nick H.S. Catalytic pathway of manganese superoxide dismutase by direct observation of superoxide. Methods. Enzymol. 349 (2002) 61-74
222. Guan Y., Hickey M.J., Borgstahl G.E., Hallewell R.A., Lepock J.R., O'Connor D., Hsieh Y., Nick H.S., Silverman D.N., and Tainer J.A. Crystal structure of Y34F mutant human mitochondrial manganese superoxide dismutase and the functional role of tyrosine 34. Biochemistry 37 (1998) 4722-4730
223. Leveque V.J., Stroupe M.E., Lepock J.R., Cabelli D.E., Tainer J.A., Nick H.S., and Silverman D.N. Multiple replacements of glutamine 143 in human manganese superoxide dismutase: effects on structure, stability, and catalysis. Biochemistry 39 (2000) 7131-7137
224. Hearn A.S., Stroupe M.E., Cabelli D.E., Ramilo C.A., Luba J.P., Tainer J.A., Nick H.S., and Silverman D.N. Catalytic and structural effects of amino acid substitution at histidine 30 in human manganese superoxide dismutase: insertion of valine C gamma into the substrate access channel. Biochemistry 42 (2003) 2781-2789
225. Hearn A.S., Fan L., Lepock J.R., Luba J.P., Greenleaf W.B., Cabelli D.E., Tainer J.A., Nick H.S., and Silverman D.N. Amino acid substitution at the dimeric interface of human manganese superoxide dismutase. J. Biol. Chem. 279 (2004) 5861-5866
226. Greenleaf W.B., Perry J.J., Hearn A.S., Cabelli D.E., Lepock J.R., Stroupe M.E., Tainer J.A., Nick H.S., and Silverman D.N. Role of hydrogen bonding in the active site of human manganese superoxide dismutase. Biochemistry 43 (2004) 7038-7045
227. Ayala I., Perry J.J., Szczepanski J., Tainer J.A., Vala M.T., Nick H.S., and Silverman D.N. Hydrogen bonding in human manganese superoxide dismutase containing 3-fluorotyrosine. Biophys. J. 89 (2005) 4171-4179
228. Quint P., Reutzel R., Mikulski R., McKenna R., and Silverman D.N. Crystal structure of nitrated human manganese superoxide dismutase: mechanism of inactivation. Free Radic. Biol. Med. 40 (2006) 453-458
229. Ren X., Tu C., Bhatt D., Perry J.J.P., Tainer J.A., Cabelli D.E., and Silverman D.N. Kinetic and structural characterization of human manganese superoxide dismutase containing 3-fluorotyrosines. J. Mol. Struct. 790 (2006) 168-173
230. Cabelli D.E., Guan Y., Leveque V., Hearn A.S., Tainer J.A., Nick H.S., and Silverman D.N. Role of tryptophan 161 in catalysis by human manganese superoxide dismutase. Biochemistry 38 (1999) 11686-11692
231. Perry J.J., Hearn A.S., Cabelli D.E., Nick H.S., Tainer J.A., and Silverman D.N. Contribution of human manganese superoxide dismutase tyrosine 34 to structure and catalysis. Biochemistry 48 (2009) 3417-3424
232. Whittaker J.W. Prokaryotic manganese superoxide dismutases. Methods. Enzymol. 349 (2002) 80-90
233. Parker M.W., and Blake C.C. Iron-and manganese-containing superoxide dismutases can be distinguished by analysis of their primary structures. FEBS Lett. 229 (1988) 377-382
234. Parker M.W., Blake C.C., Barra D., Bossa F., Schinina M.E., Bannister W.H., and Bannister J.V. Structural identity between the iron-and manganese-containing superoxide dismutases. Protein Eng. 1 (1987) 393-397
235. Yamakura F., Kobayashi K., Ue H., and Konno M. The pH-dependent changes of the enzymic activity and spectroscopic properties of iron-substituted manganese superoxide dismutase. A study on the metal-specific activity of Mn-containing superoxide dismutase. Eur. J. Biochem. 227 (1995) 700-706
236. Whittaker M.M., and Whittaker J.W. Mutagenesis of a proton linkage pathway in Escherichia coli manganese superoxide dismutase. Biochemistry 36 (1997) 8923-8931
237. Edwards R.A., Whittaker M.M., Whittaker J.W., Jameson G.B., and Baker E.N. Distinct metal environment in Fe-substituted manganese superoxide dismutase provides a structural basis of metal specificity. J. Am. Chem. Soc. 120 (1998) 9684-9685
238. Vance C.K., and Miller A.F. Spectroscopic comparisons of the pH dependencies of Fe-substituted (Mn)superoxide dismutase and Fe-superoxide dismutase. Biochemistry 37 (1998) 5518-5527
239. Martin M.E., Byers B.R., Olson M.O., Salin M.L., Arceneaux J.E., and Tolbert C. A Streptococcus mutans superoxide dismutase that is active with either manganese or iron as a cofactor. J. Biol. Chem. 261 (1986) 9361-9367
240. Sugio S., Hiraoka B.Y., and Yamakura F. Crystal structure of cambialistic superoxide dismutase from porphyromonas gingivalis. Eur. J. Biochem. 267 (2000) 3487-3495
241. Hsieh Y., Guan Y., Tu C., Bratt P.J., Angerhofer A., Lepock J.R., Hickey M.J., Tainer J.A., Nick H.S., and Silverman D.N. Probing the active site of human manganese superoxide dismutase: the role of glutamine 143. Biochemistry 37 (1998) 4731-4739
242. Chockalingam K., Luba J., Nick H.S., Silverman D.N., and Zhao H. Engineering and characterization of human manganese superoxide dismutase mutants with high activity and low product inhibition. FEBS J. 273 (2006) 4853-4861
243. Davis C.A., Hearn A.S., Fletcher B., Bickford J., Garcia J.E., Leveque V., Melendez J.A., Silverman D.N., Zucali J., Agarwal A., and Nick H.S. Potent anti-tumor effects of an active site mutant of human manganese-superoxide dismutase. Evolutionary conservation of product inhibition. J. Biol. Chem. 279 (2004) 12769-12776
244. Szabo C., Ischiropoulos H., and Radi R. Peroxynitrite: biochemistry pathophysiology and development of therapeutics. Nat. Rev. Drug Discovery 6 (2007) 662-680
245. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 1620-1624
246. Peluffo G., and Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc. Res. 75 (2007) 291-302
247. Youn H.D., Kim E.J., Roe J.H., Hah Y.C., and Kang S.O. A novel nickel-containing superoxide dismutase from Streptomyces spp. Biochem. J. 318 Pt. 3 (1996) 889-896
248. Youn H.D., Youn H., Lee J.W., Yim Y.I., Lee J.K., Hah Y.C., and Kang S.O. Unique isozymes of superoxide dismutase in Streptomyces griseus. Arch. Biochem. Biophys. 334 (1996) 341-348
249. Palenik B., Brahamsha B., Larimer F.W., Land M., Hauser L., Chain P., Lamerdin J., Regala W., Allen E.E., McCarren J., Paulsen I., Dufresne A., Partensky F., Webb E.A., and Waterbury J. The genome of a motile marine Synechococcus. Nature 424 (2003) 1037-1042
250. Schmidt A., Gube M., and Kothe E. In silico analysis of nickel containing superoxide dismutase evolution and regulation. J. Basic Microbiol. 49 (2009) 109-118
251. Choudhury S.B., Lee J.W., Davidson G., Yim Y.I., Bose K., Sharma M.L., Kang S.O., Cabelli D.E., and Maroney M.J. Examination of the nickel site structure and reaction mechanism in Streptomyces seoulensis superoxide dismutase. Biochemistry 38 (1999) 3744-3752
252. Barondeau D.P., Kassmann C.J., Bruns C.K., Tainer J.A., and Getzoff E.D. Nickel superoxide dismutase structure and mechanism. Biochemistry 43 (2004) 8038-8047
253. Wuerges J., Lee J.W., Yim Y.I., Yim H.S., Kang S.O., and Djinovic Carugo K. Crystal structure of nickel-containing superoxide dismutase reveals another type of active site. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8569-8574
254. Kim E.J., Chung H.J., Suh B., Hah Y.C., and Roe J.H. Transcriptional and post-transcriptional regulation by nickel of sodN gene encoding nickel-containing superoxide dismutase from Streptomyces coelicolor Muller. Mol. Microbiol. 27 (1998) 187-195
255. Banci L., Bertini I., Cabelli D.E., Hallewell R.A., Luchinat C., and Viezzoli M.S. Advances in the understanding of the structure-function relationship in Cu,Zn superoxide dismutase. Free Radic. Res. Commun. 12-13 Pt 1 (1991) 239-251
256. Miller A.F., Padmakumar K., Sorkin D.L., Karapetian A., and Vance C.K. Proton-coupled electron transfer in Fe-superoxide dismutase and Mn-superoxide dismutase. J. Inorg. Biochem. 93 (2003) 71-83
257. Maliekal J., Karapetian A., Vance C., Yikilmaz E., Wu Q., Jackson T., Brunold T.C., Spiro T.G., and Miller A.F. Comparison and contrasts between the active site PKs of Mn-superoxide dismutase and those of Fe-superoxide dismutase. J. Am. Chem. Soc. 124 (2002) 15064-15075
258. Hunter T., Ikebukuro K., Bannister W.H., Bannister J.V., and Hunter G.J. The conserved residue tyrosine 34 is essential for maximal activity of iron-superoxide dismutase from Escherichia coli. Biochemistry 36 (1997) 4925-4933
259. Holm R.H., Kennepohl P., and Solomon E.I. structural and functional aspects of metal sites in biology. Chem. Rev. 96 (1996) 2239-2314
260. Miller A.F. Redox tuning over almost 1 V in a structurally conserved active site: lessons from Fe-containing superoxide dismutase. Acc. Chem. Res. 41 (2008) 501-510
261. Maroney M.J. Structure/function relationships in nickel metallobiochemistry. Curr. Opin. Chem. Biol. 3 (1999) 188-199
262. Fiedler A.T., Bryngelson P.A., Maroney M.J., and Brunold T.C. Spectroscopic and computational studies of Ni superoxide dismutase: electronic structure contributions to enzymatic function. J. Am. Chem. Soc. 127 (2005) 5449-5462
263. Pelmenschikov V., and Siegbahn P.E. Nickel superoxide dismutase reaction mechanism studied by hybrid density functional methods. J. Am. Chem. Soc. 128 (2006) 7466-7475
264. Herbst R.W., Guce A., Bryngelson P.A., Higgins K.A., Ryan K.C., Cabelli D.E., Garman S.C., and Maroney M.J. Role of conserved tyrosine residues in NiSOD catalysis: a case of convergent evolution. Biochemistry 48 (2009) 3354-3369
265. Tietze D., Breitzke H., Imhof D., Kothe E., Weston J., and Buntkowsky G. New insight into the mode of action of nickel superoxide dismutase by investigating metallopeptide substrate models. Chemistry 15 (2009) 517-523
266. Bannister W.H., Bannister J.V., Barra D., Bond J., and Bossa F. Evolutionary aspects of superoxide dismutase: the copper/zinc enzyme. Free. Radic. Res. Commun. 12 Pt. 1 (1991) 349-361
267. Harrigan J.A., Piotrowski J., Di Noto L., Levine R.L., and Bohr V.A. Metal-catalyzed oxidation of the Werner syndrome protein causes loss of catalytic activities and impaired protein-protein interactions. J. Biol. Chem. 282 (2007) 36403-36411
268. Perry J.J., Yannone S.M., Holden L.G., Hitomi C., Asaithamby A., Han S., Cooper P.K., Chen D.J., and Tainer J.A. WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing. Nat. Struct. Mol. Biol. 13 (2006) 414-422
269. Shen J.C., Gray M.D., Oshima J., Kamath-Loeb A.S., Fry M., and Loeb L.A. Werner syndrome protein. I. DNA helicase and dna exonuclease reside on the same polypeptide. J. Biol. Chem. 273 (1998) 34139-34144
270. Bohr V.A. Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance. Trends Biochem. Sci. 33 (2008) 609-620
271. Ozgenc A., and Loeb L.A. Werner Syndrome, aging and cancer. Genome Dyn. 1 (2006) 206-217
272. Beckman J.S., Chen J., Ischiropoulos H., and Crow J.P. Oxidative chemistry of peroxynitrite. Methods Enzymol. 233 (1994) 229-240
273. Beckmann J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., and White C.R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler 375 (1994) 81-88
274. Eiserich J.P., Vossen V., O'Neill C.A., Halliwell B., Cross C.E., and van der Vliet A. Molecular mechanisms of damage by excess nitrogen oxides: nitration of tyrosine by gas-phase cigarette smoke. FEBS Lett. 353 (1994) 53-56
275. Beckman J.S., Chen J., Crow J.P., and Ye Y.Z. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog. Brain Res. 103 (1994) 371-380
276. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 57 (1993) 779S-785S discussion 785S-786S
277. Harman D. Free radical theory of aging. Mutat. Res. 275 (1992) 257-266
278. Shigenaga M.K., Hagen T.M., and Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 10771-10778
279. Fan L., Fuss J.O., Cheng Q.J., Arvai A.S., Hammel M., Roberts V.A., Cooper P.K., and Tainer J.A. XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations. Cell 133 (2008) 789-800
280. Williams R.S., Moncalian G., Williams J.S., Yamada Y., Limbo O., Shin D.S., Groocock L.M., Cahill D., Hitomi C., Guenther G., Moiani D., Carney J.P., Russell P., and Tainer J.A. Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair. Cell 135 (2008) 97-109
281. Williams R.S., Dodson G.E., Limbo O., Yamada Y., Williams J.S., Guenther G., Classen S., Glover J.N., Iwasaki H., Russell P., and Tainer J.A. Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell 139 (2009) 87-99
282. Meiering E.M. The threat of instability: neurodegeneration predicted by protein destabilization and aggregation propensity. PLoS Biol. 6 (2008) e193
283. Chiti F., Stefani M., Taddei N., Ramponi G., and Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424 (2003) 805-808
284. Valentine J.S., Doucette P.A., and Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 74 (2005) 563-593
285. Zhong Z., Ilieva H., Hallagan L., Bell R., Singh I., Paquette N., Thiyagarajan M., Deane R., Fernandez J.A., Lane S., Zlokovic A.B., Liu T., Griffin J.H., Chow N., Castellino F.J., Stojanovic K., Cleveland D.W., and Zlokovic B.V. Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. J. Clin. Invest. 119 11 (2009) 3437-3449
286. Oda T., Akaike T., Hamamoto T., Suzuki F., Hirano T., and Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244 (1989) 974-976
287. Hallewell R.A., Laria I., Tabrizi A., Carlin G., Getzoff E.D., Tainer J.A., Cousens L.S., and Mullenbach G.T. Genetically engineered polymers of human CuZn superoxide dismutase. Biochemistry and serum half-lives. J. Biol. Chem. 264 (1989) 5260-5268
288. Nelson S.K., Bose S.K., Grunwald G.K., Myhill P., and McCord J.M. The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic. Biol. Med. 40 (2006) 341-347
289. Fee J.A. Is superoxide important in oxygen poisoning?. Trends Biochem. Sci. 7 (1982) 84-86